MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11239-008-0234-x

Медицинская библиотека · Journal of thrombosis and thrombolysis · 2008

Indications of combined vitamin K antagonists and aspirin therapy.

Loualidi A, Bredie S H J, Janssen M C H

СтатьяОбзорПеревод в очереди

Аннотация

Based on their mode of action, it is reasonable to expect that the combination therapy of aspirin and a vitamin K antagonist (VKA) may be more beneficial in preventing (athero) thrombotic complications in high-risk patients for cardiovascular events. However, there is no consensus about additional aspirin use in the most common indications for VKA or the use of VKAs to be added to the most common aspirin indications. The variation in clinical outcomes and bleeding complications suggests that extrapolating from one indication to another may not be appropriate. So far, decisions about the combined use of aspirin and VKA are individualized in the absence of adequate data. Only in patients with mechanical heart valves the benefits and safety of combining aspirin with VKA therapy seems obvious. In patients with peripheral artery disease no beneficial effect was noted for the combination therapy, perhaps with an exception of those with graft failure. For all other clinical situations, this is unclear and should be avoided.

Для цитирования: Loualidi A, Bredie S H J, Janssen M C H. Indications of combined vitamin K antagonists and aspirin therapy.. Journal of thrombosis and thrombolysis. 2008. DOI: 10.1007/s11239-008-0234-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.